Skip to main content
. 2003 Jan 7;57(1):35–40. doi: 10.1016/S0166-3542(02)00198-5

Table 1.

Properties of an ideal anti-orthopoxvirus drug

Active against vaccinia, monkeypox and variola virus
Should be active orally for ease of administration
Long intracellular half-life is desirable so dosing can be infrequent
Must be stable for long periods under adverse storage conditions
Needs to be inexpensive, so large amounts can be stockpiled
Must have a tolerable safety profile also for children and immunocompromised individuals